ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.
Confluent (NASDAQ:CFLT – Get Free Report) had its price target boosted by equities researchers at Truist Financial from ...
Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold a total of 5,844 shares of the company's common stock on February 13, 2025, according to a recent SEC filing. The ...
We asked cultural commentators, a network exec, and real architects to sound off on how the profession earned its ...
Speaking from her New York home base in January, choreographer Pam Tanowitz—currently held in the warmest of embraces by critics and knowing audiences—lamented the weather, confessing, “I can’t wait ...
Reivew by Prof. Rajiva Wijesinha Edited by Avisha Mario Seneviratne When over forty years ago I produced the first volume of the New Lankan Review, which proved popular if controversial, I realised ...
An "unsinkable" ship can still sink. Read on for more facts about what happened on the 'Titanic,' from its famous passengers ...
Highlights,Guggenheim raised Tapestry's target price from $70 to $90, signaling increased market confidence.,The company ...
Learn about Dr. Robert H. Goddard's groundbreaking rocket launch in Auburn, Massachusetts, a pivotal moment in U.S. space exploration history.
Fashion entrepreneur Liz Lange is the latest in a long line of visionary women to fall under the spell of Grey Gardens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results